[Federal Register Volume 75, Number 206 (Tuesday, October 26, 2010)]
[Notices]
[Page 65641]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-27060]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]


Risk Communication Advisory Committee; Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Risk Communication Advisory Committee. 
This meeting was announced in the Federal Register of September 20, 
2010 (75 FR 57279). The amendment is being made to reflect a change in 
the Agenda portion of the document. There are no other changes.

FOR FURTHER INFORMATION CONTACT: Lee L. Zwanziger, Office of Policy, 
Planning and Budget, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 32, Rm. 3278, Silver Spring, MD 20993, 301-796-9151, FAX: 
301-847-8611, e-mail: RCAC@fda.hhs.gov, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 8732112560. Please call the Information Line for up-to-date 
information on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of September 20, 
2010, FDA announced that a meeting of the Risk Communication Advisory 
Committee would be held on November 8 and 9, 2010. On page 57280, in 
the first column, the Agenda portion of the document is changed to read 
as follows:
    Agenda: On November 8 and 9, 2010, the Committee will hear and 
discuss developments in FDA's ongoing communications programs, such as 
FDA's Strategic Plan for Risk Communication, FDA's Transparency 
Initiative, foodborne outbreaks and related recall communications, and 
the challenges of effectively communicating with patients and 
caregivers about appropriate use of medical devices when a patient is 
prescribed a medical device for home use.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: October 21, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-27060 Filed 10-25-10; 8:45 am]
BILLING CODE 4160-01-P